MWR
PFE icon

McAdams Wright Ragen’s Pfizer PFE Stock Holding History

McAdams Wright Ragen’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4.96M Buy
176,798
+11,477
+7% +$322K 0.28% 83
2014
Q2 		$4.66M Buy
165,321
+20,342
+14% +$580K 0.26% 86
2014
Q1 		$4.42M Sell
144,979
-127,196
-47% -$3.79M 0.27% 83
2013
Q4 		$7.91M Sell
272,175
-70,461
-21% -$2.05M 0.52% 54
2013
Q3 		$9.34M Sell
342,636
-19,428
-5% -$529K 0.74% 35
2013
Q2 		$9.62M Buy
+362,064
New +$10M 0.77% 32

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

McAdams Wright Ragen's PFE Position: Q3 2014 in Review

McAdams Wright Ragen increased its Pfizer (PFE) stake by 6.9% in Q3 2014, buying an estimated $322K and bringing the position to 176,798 shares worth $4.96M. The position accounts for 0.28% of the portfolio, ranked #83.

McAdams Wright Ragen first reported a position in PFE in Q2 2013 and has held it in 6 quarters since. The position peaked at $9.62M in Q2 2013. 1,741 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • McAdams Wright Ragen held 176,798 shares of Pfizer worth $4.96M as of Q3 2014.
  • McAdams Wright Ragen bought 11,477 Pfizer shares in Q3 2014, an estimated $322K.
  • Pfizer made up 0.28% of McAdams Wright Ragen's portfolio in Q3 2014, its #83 holding.
  • McAdams Wright Ragen first reported a position in Pfizer in Q2 2013 and has held it in 6 quarters since.
  • McAdams Wright Ragen's Pfizer position peaked at $9.62M in Q2 2013.
  • 1,741 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.